Heron Therapeutics, Inc. (HRTX)
NASDAQ: HRTX · Real-Time Price · USD
1.580
+0.050 (3.27%)
At close: Dec 20, 2024, 4:00 PM
1.540
-0.040 (-2.53%)
After-hours: Dec 20, 2024, 4:46 PM EST
Heron Therapeutics Employees
Heron Therapeutics had 126 employees as of December 31, 2023. The number of employees decreased by 77 or -37.93% compared to the previous year.
Employees
126
Change (1Y)
-77
Growth (1Y)
-37.93%
Revenue / Employee
$1,093,151
Profits / Employee
-$221,960
Market Cap
240.31M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Aurora Cannabis | 1,073 |
Anika Therapeutics | 357 |
BGM Group | 298 |
Pulmonx | 279 |
Electromed | 174 |
Nautilus Biotechnology | 167 |
Ocugen | 65 |
Artiva Biotherapeutics | 43 |
HRTX News
- 17 days ago - Relief For Heron Therapeutics After The Court Win On Cinvanti - Seeking Alpha
- 18 days ago - U.S. District Court Upholds Validity of CINVANTI® Patents - PRNewsWire
- 5 weeks ago - Heron Therapeutics, Inc. (HRTX) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Heron Therapeutics Announces Third Quarter 2024 Financial Results and Narrows Financial Guidance - PRNewsWire
- 6 weeks ago - Heron Therapeutics Announces Appointment of Michael Kaseta to Board of Directors - PRNewsWire
- 7 weeks ago - Heron Therapeutics to Report Third Quarter 2024 Financial Results On Tuesday, November 12, 2024 - PRNewsWire
- 2 months ago - Heron Therapeutics Reaffirms Availability and Ample Supply of CINVANTI®, SUSTOL®, and APONVIE® as Alternatives During the Potential Shortage of Intravenous Fluids - PRNewsWire
- 3 months ago - Heron Therapeutics Announces FDA Approval of the Prior Approval Supplement Application for ZYNRELEF® Vial Access Needle ("VAN") - PRNewsWire